Autophagy Modulation in Therapeutic Strategy of Breast Cancer Drug Resistance

Maoqi Wang1,2, Mianxue Liu1,2, Cheng Yang1,2

  • 1Department of General Surgery, Jiujiang Hospital of Traditional Chinese Medicine in Jiangxi Province, Jiujiang, China.

Journal of Cancer
|September 9, 2024
PubMed

Insights

Targeting cell autophagy, a key process in breast cancer (BC) progression, offers novel therapeutic strategies. Understanding autophagy

Area of Science:

  • Oncology and Molecular Biology: Focuses on cellular mechanisms in cancer.

Background:

  • Breast cancer (BC) is a widespread global malignancy.
  • Autophagy is integral to BC development, metastasis, and onset.
  • Chemotherapeutics can modulate autophagy in tumor cells, leading to debate on its role in treatment efficacy.

Purpose of the Study:

  • To review current research on autophagy mechanisms in breast cancer.
  • To explore autophagy-based therapeutic strategies for BC.
  • To identify new directions for BC treatment.

Main Methods:

  • Literature review of recent studies on autophagy in breast cancer.
  • Analysis of the role of autophagy modulation in BC treatment.
  • Synthesis of information on autophagy-based therapeutic techniques.

Main Results:

  • Autophagy's dual role (stimulation vs. inhibition) in enhancing anticancer drug efficacy is highlighted.
  • The critical importance of deciding whether to stimulate or inhibit autophagy during BC treatment is emphasized.
  • Understanding specific autophagy mechanisms in BC is key for targeted therapies.

Conclusions:

  • Targeting cell autophagy presents a promising strategy for breast cancer prevention and therapy.
  • Further research into autophagy's role in BC can lead to personalized treatment plans.
  • Autophagy-based approaches offer novel avenues for future breast cancer treatment.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K